Phencyclidine hydrochloride (PCP) also known as Angel Dust is a very p
otent psychotomimetic drug of abuse. Besides its central nervous syste
m (CNS) effects PCP produces a number of adverse effects in a variety
of tissues including the cardiovascular system. Since PCP is known to
alter the cellular calcium homeostasis the present studies were initia
ted to determine the changes in cardiac Ca2+ ATPase activity in rats t
reated with PCP. For in vitro studies the cardiac sarcoplasmic reticul
um (SR) fractions prepared from normal rats were incubated with 25, 50
and 100 mu M PCP and the enzyme activities were estimated. Whereas, f
or in vivo studies the cardiac SR fractions prepared from rats treated
with PCP (10 mg/kg body wt. single dose, intra-peritoneally (i.p.)) a
nd sacrificed at different time intervals were used. PCP reduced the C
a2+ ATPase activity significantly both in vitro and in vivo. A 50% inh
ibition of the enzyme activity was obtained with 100 mu M PCP in vitro
. A significant reduction of SR Ca2+ ATPase was also evident as early
as 1 h after treatment of rats with PCP. The reduction of Ca2+ ATPase
activity in SR was irreversible even at 12 h after treatment. The in v
itro kinetic studies revealed, that PCP was found to be a competitive
inhibitor of Ca2+ ATPase with respect to the substrate, ATP, and non-c
ompetitive with respect to Ca2+ activation. These results indicate tha
t PCP alters the myocardial Ca2+ homeostasis by inhibiting the Ca2+ AT
Pase in cardiac SR in rats. Inhibition of SR Ca2+ ATPase may result in
the impairment of contraction and relaxation coupling processes in th
e myocardium. (C) 1998 Elsevier Science Ireland Ltd. All rights reserv
ed.